Allocation and dynamics of inducible nitric oxide synthase expression in patients with rectal cancer under the influence of neoadjuvant chemoradiotherapy and their relationship with efficiency of polyradiomodification with the usage of L-arginine.
DOI:
https://doi.org/10.26641/1997-9665.2016.3.99-103Keywords:
rectal carcinoma, medical pathomorphosis, chemoradiation therapy, nitric oxide, inducible nitric oxide synthase, immunohistochemistryAbstract
Background. Considering the importance of nitric oxide in the malignant growth pathogenesis, researchers are actively exploring properties of nitric oxide synthesis biological systems in colorectal cancer tumors. However, literature data according the characteristics of iNOS expression in colorectal cancer and its prognostic and predictive value is ambiguous. Objective: to define the features of iNOS expression in intact colon and rectal cancer tissues before treatment and after the course of neoadjuvant chemoradiotherapy, including the background of the drug precursor of nitric oxide. Methods. iNOS expression indexes were determined by immunohistochemistry in the biopsy and surgical material in 24 patients with adenocarcinoma of the rectum stage II-III before and after neoadjuvant chemoradiotherapy. Results. It was revealed 4.5 times higher levels of iNOS expression in the rectal cancer tumor compared with intact mucosa. Rectal cancer iNOS is expressed in tumor parenchyma cells and in tumor stroma, the level of immunosignal in stroma is 24% higher compared with parenchyma. Positive correlation (r= 0.74; р<0.05) of iNOS expression in the tumor with metastatic lesion of regional lymph nodes was established in rectal cancer patients. High expression level of iNOS in rectal cancer tissue is a positive predictive factor for the effectiveness of radiation therapy on the background polyradiomodification using tegafur and L-arginine. Conclusion. Discovered peculiarities of iNOS expression indicate the advisability of taking into account this marker when planning neoadjuvant therapy of patients with rectal cancer and establishing the risk of disease progression.References
- Choudhari SK, Chaudhary M, Bagde S, Gadbail AR, Joshi V. Nitric oxide and cancer: a review. World J Surg Oncol. 2013; 11:118. doi: 10.1186/1477-7819-11-118.
- Wink DA, Hines HB, Cheng RY, Switzer CH, Flores-Santana W, Vitek MP, Ridnour LA, Colton CA. Nitric oxide and redox mechanisms in the immune response. J Leukoc Biol. 2011 Jun; 89(6):873-91. doi: 10.1189/jlb.1010550.
- Blaise GA, Gauvin D, Gangal M, Authier S. Nitric oxide, cell signaling and cell death. Toxicology. 2005 Mar 15; 208(2):177-92.
- Huerta S, Chilka S, Bonavida B. Nitric oxide donors: novel cancer therapeutics (review). Int J Oncol. 2008 Nov; 33(5):909-27.
- Stuehr DJ. Enzymes of the L-arginine to nitric oxide pathway. J Nutr. 2004 Oct; 134(10 Suppl):2748S-2751S; discussion 2765S-2767S.
- Rahat MA, Hemmerlein B. Macrophage-tumor cell interactions regulate the function of nitric oxide. Front Physiol. 2013 Jun 18; 4:144. doi: 10.3389/fphys.2013.00144.
- Zafirellis K, Zachaki A, Agrogiannis G, Gravani K. Inducible nitric oxide synthase expression and its prognostic significance in colorectal cancer. APMIS. 2010 Feb; 118(2):115-24. doi: 10.1111/j.1600-0463.2009.02569.x.
- Gochman E, Mahajna J, Shenzer P, Dahan A, Blatt A, Elyakim R, Reznick AZ. The expression of iNOS and nitrotyrosine in colitis and colon cancer in humans. Acta Histochem. 2012 Dec; 114(8):827-35. doi: 10.1016/j.acthis.2012.02.004.
Downloads
How to Cite
Golotiuk, V. V., & Bagriy, M. M. (2016). Allocation and dynamics of inducible nitric oxide synthase expression in patients with rectal cancer under the influence of neoadjuvant chemoradiotherapy and their relationship with efficiency of polyradiomodification with the usage of L-arginine. Морфологія / Morphologia / Morfologìâ, 10(3), 99–103. https://doi.org/10.26641/1997-9665.2016.3.99-103
Issue
Section
Статті
License
Copyright (c) 2018 Morphologia

This work is licensed under a Creative Commons Attribution 4.0 International License.
The authors reserve the right to authorship of their work and transfer to the Journal the right to the first publication of this work under the terms of a license Creative commons Attribution 4.0 International (CC BY 4.0), which allows other people to freely distribute the published work with a mandatory reference to the authors of the original work and the first publication of the work in this journal.By submitting a manuscript to the editorial office of the Journal ‘Morphologia’ authors agree to transfer the rights to protect and use the manuscript (all supplemental materials, particularly protected objects such as photos, drawings, diagrams, tables, etc.), including the reproduction in the press and distribution via the Internet; translation of the manuscript into any language; export and import of journal copies with the Authors’ article in order to make it available for public. Authors convey the rights mentioned above to the editorial office without any temporal or territorial limitation all over the world.
The Authors guarantee that they have the exclusive rights to use the material transferred to editorial office. Editors are not responsible to third parties for contraventions of warranty given by the Authors. The considered rights are transferred to the editorial office since the moment when the current issue is signed for publishing. Reproduction of materials published in the Journal by other individuals and legal entities is possible only with the consent of Editorial office, with the obligatory indication of the full bibliographic reference of the primary publication. The Authors reserve the right to use the published material, its fragments and parts for teaching materials, oral presentations, dissertation thesis prepararion with obligatory bibliographic citation of the original paper. Electron copy of the published article, downloaded from official journal web-site in .pdf format may be put by authors on the official web-site of their institutions, any other official resources with open access.
